Safety/Efficacy of Systane Free vs Refresh Tears
Not Applicable
Completed
- Conditions
- Dry Eye
- Registration Number
- NCT00348322
- Lead Sponsor
- Alcon Research
- Brief Summary
The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Tears Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- > = 3 stain using NEI grid and need artificial tears at least some of the time.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Corneal Staining change from baseline
- Secondary Outcome Measures
Name Time Method Comfort, Conjunctival Staining
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate Systane Free from Refresh Tears in dry eye treatment?
How does Systane Free compare to standard-of-care artificial tears in dry eye symptom relief?
Which biomarkers correlate with improved tear film stability in Systane Free vs Refresh Tears?
What adverse events are associated with Systane Free in dry eye clinical trials?
Are there combination therapies involving Systane Free for managing evaporative dry eye?
Trial Locations
- Locations (1)
El Paso Facility
🇺🇸El Paso, Texas, United States
El Paso Facility🇺🇸El Paso, Texas, United States